Tuberculosis infection related hemophagocytic lymphohistiocytosis diagnosed in patient with GZMB mutation: A case report and literature review. Issue 35 (2nd September 2022)

• Record Type: Journal Article
• Authors: Wang, Zhenhao; Zhang, Jin; Hao, Zhaonian; Meng, Li; Han, Zhiqiang; Hong, Zhenya
• Is Part Of: Medicine. Volume 101:Issue 35(2022)
• Page Start: e30283
• Publication Date: 2022-09-02
• Subjects: GZMB -- Hemophagocytic lymphohistiocytosis -- Metagenomic next-generation sequencing -- Mycobacterium tuberculosis; Medicine -- Periodicals; Medicine -- Periodicals; Médecine -- Périodiques; Geneeskunde; Medicine; Periodicals; Periodicals; 610.5
• DOI: 10.1097/MD.0000000000030283
• Languages: English
• ISSNs: 0025-7974

Abstract

Abstract : Background: Secondary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome associated with infections, tumors and connective tissue disease. However rapid identification of the underlying infectious cause of HLH is challenging because traditional etiological diagnostics are time-consuming and sometimes fail to identify the pathogens. Metagenomic next-generation sequencing (mNGS) may be a potential optimal solution, which may help improve the clinical diagnosis of underlying infections in hematological diseases. Case presentation: A 28-year-old man presented with a 2-month history of intermittent fever and cytopenia. The HLH was diagnosed based on the manifestations of fever, splenomegaly, anemia, thrombocytopenia, hyperferritinemia, hyperglyceridemia, and elevated IL-2R levels. High-through-put sequencing analysis detected a GZMB mutation. While the initial detection of cultures and smears of tuberculosis was negative, TB infection was eventually identified by mNGS of blood sample. The symptoms rapidly abated during the initial administration of TB. Conclusion: The present case proposed that mNGS might be an effective diagnostic tool for diagnosing rare infectious cause of secondary HLH. GZMB mutation was first discovered to be present in secondary HLH.